Lamivudine is a medication used in the management and treatment of HIV-1 and hepatitis B. It is in the nucleoside reverse transcriptase inhibitor (NRTI) class of medications. This activity outlines the indications, mechanism of action, and contraindications for lamivudine as a valuable agent in the therapy for HIV (and other disorders when applicable). This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the healthcare team in the care of patients with HIV and hepatitis B.

**Objectives:**
- Identify the mechanism of action of lamivudine.
- Describe the adverse effects of lamivudine.
- Review the appropriate monitoring of lamivudine.
- Outline some interprofessional team strategies for improving care coordination and communication to advance lamivudine and improve outcomes.